MING HSIEH

Chairman & Chief Executive Fulgent Genetics Inc.

Hsieh founded Fulgent Genetics in 2011 with the goal of providing comprehensive yet affordable genetic testing. When the Covid-19 pandemic hit, Fulgent quickly pivoted to Covid testing and snagged major testing contracts for public agencies in Los Angeles and across the nation. Demand was so high that Fulgent opened a testing lab in Houston to supplement its lab near its Temple City headquarters. The company’s 2020 revenue surged 1,200% to $422 million; revenue leapt again in 2021 to $993 million. Prior to Fulgent, Hsieh co-founded biometric identification services and products company Cogent Inc. in 1990, which was acquired in 2010. Hsieh, a USC graduate, has served as a trustee at USC since 2007.